Inventiva (IVA) Non Operating Income (2020 - 2021)
Inventiva (IVA) posted quarterly Non Operating Income of -$735809.8 for Q2 2021, down 66703.13% year-over-year from N/an in Q2 2020, and down 142.51% quarter-over-quarter from $1.7 million in Q1 2021.
Powered by 
Analysis
Inventiva (IVA) Non Operating Income (2020 - 2021) Analysis & Trends
Inventiva's Non Operating Income history runs 2 years deep, the most recent figure standing at -$735809.8 for Q2 2021.
- In Q2 2021, Non Operating Income fell 66703.13% year-over-year to -$735809.8; the TTM figure through Jun 2021 stood at -$3.7 million (changed N/A YoY), while the FY2025 annual figure was -$247.7 million, down 169.45% from the prior year.
- Non Operating Income for Q2 2021 stood at -$735809.8, down from $1.7 million in the prior quarter.
- The five-year high for Non Operating Income was $1.7 million in Q1 2021, with the low at -$4.7 million in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -139.24 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -53.64 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -51.63 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Inventiva | 893.85 Mn | 893.85 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | 1.73 Mn |
| Jun 30, 2020 | -1,101.46 |
| Mar 31, 2020 | 7,727.57 |